Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading – for better or worse – and then I do my best to make sense of who’s moving where and why it might be happening.

Here’s what’s been happening since the doors were opened this morning…

 

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code Company Price % Volume Market Cap
SLZ Sultan Resources Ltd 0.022 38% 637,000 SLZ
RML Resolution Minerals 0.004 33% 12,500 RML
ABC Adbri Limited 2.95 30% 1,013,473 ABC
M2M Mtmalcolmminesnl 0.032 28% 1,332,751 M2M
NEU Neuren Pharmaceut. 21.83 27% 576,296 NEU
LNK Link Admin Hldg 2.165 27% 894,669 LNK
LIS Lisenergylimited 0.225 22% 298,936 LIS
CAV Carnavale Resources 0.006 20% 238,904 CAV
RVS Revasum 0.155 19% 4,833 RVS
ZNC Zenith Minerals Ltd 0.165 18% 6,021 ZNC
Wordpress Table Plugin

 

Mt Malcolm Mines (ASX:M2M) is on the move this morning, on news of visual confirmation of the presence of pegmatite in historic drill spoil following an on-ground inspection of the Company’s Lake Johnston Project’s tenure.

Sultan Resources (ASX:SLZ) is up this morning, since revealing last week that it submitted a programme of works to facilitate drilling to test the Calesi magmatic nickel prospect, which is the subject of a farm-in agreement with Rio Tinto Exploration (RTX), a subsidiary of Rio Tinto.

Large cap Adbri (ASX:ABC) is soaring this morning, up around 30% after the company revealed it had received a non-binding indicative takeover proposal from CRH and the Barro Group at a price of $3.20 cash per share, a 41% premium to last close.

Another large cap, Neuren Pharmaceuticals (ASX:NEU), is rising very quickly this morning, following news of positive feedback from its Phase 2 trial of NNZ-2591 in children with Phelan-McDermid syndrome, including “significant” improvements that were “consistently seen across clinically important aspects of Phelan-McDermid syndrome, including communication, behaviour, cognition/learning and socialisation”.

Link Administration Holdings (ASX:LNK) is climbing quickly this morning, on news that it has entered into a scheme implementation deed with Mitsubishi UFJ Trust & Banking Corporation (The Trust Bank), a consolidated subsidiary of Mitsubishi UFJ Financial Group, under which The Trust Bank has agreed to acquire 100% of the shares in Link Group by way of a scheme of arrangement.

 

LOSERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code Company Price % Volume Market Cap
STK Strickland Metals 0.098 -39% 12,790,904 $261,001,611
KEY KEY Petroleum 0.001 -33% 1,000,000 $2,951,892
VML Vital Metals Limited 0.007 -30% 5,585,195 $53,061,498
RHY Rhythm Biosciences 0.145 -22% 616,262 $40,911,379
HCT Holista CollTech Ltd 0.011 -21% 106,364 $3,903,201
88E 88 Energy Ltd 0.004 -20% 1,445,018 $123,204,013
KPO Kalina Power Limited 0.004 -20% 100,020 $11,050,640
MYE Metarock Group Ltd 0.11 -15% 29,978 $39,788,669
IBG Ironbark Zinc Ltd 0.006 -14% 14,772 $11,157,108
OAR OAR Resources Ltd 0.003 -14% 2 $9,243,713
Wordpress Table Plugin

 

Strickland Metals (ASX:STK) is falling this morning, despite news of “excellent drill results” from the first three diamond holes and four RC holes from the initial 19 hole program at Marwari.

Rhythm Biosciences (ASX:RHY) is down this morning after releasing an update into the company’s progress, as it “its operations and resources … to adopt the new stringent IVDR (In Vitro Diagnostic Medical Device Regulation) requirements for all products in development”.

Vital Metals (ASX:VML) is showing a drop this morning, after it finalised the issue of 588,917,200 shares to Shenghe Resources at $0.01 per share to raise approximately A$5.9 million, alongside an agreement to sell its stockpiled rare earth material to Shenghe for approximately A$2.6 million, leaving the company “funded to deliver into key milestones in 2024”.